120 related articles for article (PubMed ID: 9804241)
1. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary.
Daraï E; Bringuier AF; Walker-Combrouze F; Feldmann G; Madelenat P; Scoazec JY
Hum Reprod; 1998 Oct; 13(1O):2831-5. PubMed ID: 9804241
[TBL] [Abstract][Full Text] [Related]
2. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
[TBL] [Abstract][Full Text] [Related]
3. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.
Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY
Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.
Chudecka-Głaz A; Rzepka-Górska I
Eur J Gynaecol Oncol; 2008; 29(1):37-42. PubMed ID: 18386461
[TBL] [Abstract][Full Text] [Related]
7. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in adnexal masses.
Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence.
Griffiths TR; Brotherick I; Bishop RI; White MD; McKenna DM; Horne CH; Shenton BK; Neal DE; Mellon JK
Br J Cancer; 1996 Aug; 74(4):579-84. PubMed ID: 8761373
[TBL] [Abstract][Full Text] [Related]
10. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.
Gogali A; Charalabopoulos K; Zampira I; Konstantinidis AK; Tachmazoglou F; Daskalopoulos G; Constantopoulos SH; Dalavanga Y
Chest; 2010 Nov; 138(5):1173-9. PubMed ID: 20495107
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
12. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
[TBL] [Abstract][Full Text] [Related]
13. Early inflammatory response in epithelial ovarian tumor cyst fluids.
Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
[TBL] [Abstract][Full Text] [Related]
14. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
[TBL] [Abstract][Full Text] [Related]
16. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of soluble intracellular adhesion molecule-1 (sICAM-1) in women with benign ovarian tumors].
Rzymski P; Opala T; Woźniak J; Drews K; Sajdak S
Ginekol Pol; 2004 Oct; 75(10):785-92. PubMed ID: 15587910
[TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
Haeger M; Swahn M; Hahlin M; Horvath G; Bengtsson A
Anticancer Res; 1996; 16(5B):3189-92. PubMed ID: 8967734
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
Wahlberg K; Høyer-Hansen G; Casslén B
Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
